Quarter Financials
Taysha Gene Therapies, Inc. (TSHA)
$0.65
-0.00 (-0.31%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Net Income | -140 | -26 | -34 | -50 | -50 | -51 | -41 | -32 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -401 | -346 | -320 | -286 | -236 | -185 | -134 | -93 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Capital Expenditure | -10 | -10 | -8 | -11 | -2 | -4 | -8 | -1 |
|---|
| Net PPE | 26 | 64 | 61 | 55 | 51 | 41 | 34 | 2 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|